CHD and respiratory syncytial virus: global expert exchange recommendations
CHD and respiratory syncytial virus: global expert exchange recommendations
About this item
Full title
Author / Creator
Publisher
Cambridge, UK: Cambridge University Press
Journal title
Language
English
Formats
Publication information
Publisher
Cambridge, UK: Cambridge University Press
Subjects
More information
Scope and Contents
Contents
Palivizumab is the standard immunoprophylaxis against serious disease due to respiratory syncytial virus infection. Current evidence-based prophylaxis guidelines may not address certain children with CHD within specific high-risk groups or clinical/management settings.
An international steering committee of clinicians with expertise in paediatri...
Alternative Titles
Full title
CHD and respiratory syncytial virus: global expert exchange recommendations
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1910796517
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1910796517
Other Identifiers
ISSN
1047-9511
E-ISSN
1467-1107
DOI
10.1017/S1047951117000609
